Gastric carcinogenesis is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. We analysed the patterns of chromosomal instability in 35 gastric carcinomas and their clinical correlations. With microarray competitive genomic hybridization, genomewide chromosomal copy number changes can be studied with high resolution and sensitivity. A genomewide scanning array with 2275 BAC and P1 clones spotted in triplicate was used. This array provided an average resolution of 1.4 Mb across the genome. Patterns of chromosomal aberrations were analysed by hierarchical cluster analysis of the normalized log 2 tumour to normal fluorescence ratios of all clones, and cluster membership was correlated to clinicopathological data including survival. Hierarchical cluster analysis revealed three groups with different genomic profiles that correlated significantly with lymph node status (P ¼ 0.02). Moreover, gastric cancer cases from cluster 3 showed a significantly better prognosis than those from clusters 1 and 2 (P ¼ 0.02). Genomic profiling of gastric adenocarcinomas based on microarray analysis of chromosomal copy number changes predicted lymph node status and survival. The possibility to discriminate between patients with a high risk of lymph node metastasis could clinically be helpful for selecting patients for extended lymph node resection.
Introduction
Gastric adenocarcinoma is the fourth most common cause of cancer death worldwide and ranks fifth in The Netherlands, with approximately 2200 new cases annually (Parkin, 2001; Visser, 2001) . Helicobacter pylori (H. pylori) is a major aetiologic factor probably interacting with dietary factors, and possibly EpsteinBarr virus also plays a role in a subset of cases (Sipponen et al., 1998; Ekstrom et al., 2001; Hausen zur et al., 2001) . Despite the high incidence of this tumour, knowledge of the genetic events leading to gastric cancer is still limited. For a gastric epithelial cell to transform to a cancer cell, it must be capable of autonomous proliferation, motility, destruction of the basal membrane, remodelling of the intercellular matrix, stroma induction and angiogenesis, and ultimately it must escape from the immune system. In gastric cancer, tumour cells acquire these features by an accumulation of genetic changes that to a large extend occur at the chromosomal level, which can be well analysed by microarray Comparative Genomic Hybridization (CGH).
Analysis of chromosomal imbalances by chromosome CGH has greatly contributed to the current knowledge of genomic alterations associated with gastric cancer and several chromosomal regions with frequent gains or losses have been identified (Koizumi et al., 1997; Kokkola et al., 1997; Wu et al., 1997; Koo et al., 2000; Grieken van et al., 2000; Hausen zur et al., 2001) . However, the information obtained is limited to a resolution of approximately 3-10 Mb. Furthermore, chromosome CGH data are less well suited for quantitative analyses like genomic tumour profiling.
In the present study, we set out to obtain genomic tumour profiles of a series of 35 gastric adenocarcinomas, to survey for different classes of tumour profiles, and to correlate these with clinicopathological tumour characteristics and patient survival data.
Results
All 35 cancers showed chromosomal aberrations. The mean number of chromosomal events (gains, losses, and amplifications) per case was 16.0 (range 3-53), with on average 7.9 gains (range 1-28), 7.1 losses (range 0-23), and 1.0 amplification (range 0-4; in 16/35 carcinomas). The total number of chromosomal aberrations ('events') correlated significantly to the number of amplifications (r ¼ 0.7, Po0.0001).
Univariate analysis was performed to detect potential differences between microarray CGH data and clinicopathological variables. No significant differences were found between average number of events, gains, losses, or amplifications, versus lymph node status, age, sex, grade, stage, or histological type.
Genomic profiling
Hierarchical cluster analysis of the microarray CGH results revealed three clusters of gastric cancers with cluster 1 containing 12 cancers, cluster 2 eight cancers, and cluster 3 fifteen cancers. Particularly clusters 1 and 3 showed clearly different patterns of chromosomal aberrations, while cluster 2 showed an intermediate pattern of chromosomal changes (Figure 1 ). The mean number of events, gains, losses, and amplifications for the different clusters are summarized in Table 1 .
ANOVA with 'leave-one-out' cross validation yielded a set of 204 clones with most significant variation between the three clusters ( Figure 2 ). These were plotted as a 'signature' for each of the three clusters (Figure 3) .
The characteristics of patients within each cluster are given in Table 2 , specified for age, sex, tumour grade, stage, histological type, and lymph node status. The prevalence of lymph node metastases was the only characteristic with significant differences between the clusters. Positive nodes were found in 10/12 (83%) and 7/8 (88%) patients in clusters 1 and 2, respectively, versus 6/15 (40%) in cluster 3 (P ¼ 0.02). In the 'leaveone-out' cluster analysis, the mean P-value for lymph node status versus cluster membership was 0.015 (range 0.001-0.15). Only one out of 35 clustering results showed a P-value >0.05.
Two patients were lost from follow-up, while four perioperative deaths (within 1 month of operation) occurred, for which reason these patients were excluded from survival analysis, leaving 29 patients in the study (Table 3 ). Since death of disease was used as outcome parameter, deaths because of causes other than gastric cancer (n ¼ 2) were treated as censored observations. The mean follow-up time was 21.2 months (range 2-104 months). Survival was significantly better in cluster 3 than clusters 1 and 2 (Figure 4 ). Given the fact that survival of patients in clusters 1 and 2 was similar, these clusters were combined in the further analyses. KaplanMeier survival analysis revealed a significant difference between cluster 3 versus clusters 1 and 2 combined (P ¼ 0.019), log-rank statistic 5.54, hazard ratio 4.1 (95% confidence interval 1.1-14.7). In the 'leave-oneout' cluster analysis, the mean P-value for survival versus cluster membership was 0.038 (range 0.004-0.49), and three out of 35 clustering results showed a P-value >0.05.
Survival also correlated with lymph node status (P ¼ 0.015, log-rank statistic 5.93), but no correlation was found between clinicopathological characteristics (age, sex, grade, stage, and type) and survival.
Discussion
Diagnostic tumour pathology aims to facilitate clinical decision making by obtaining as much information from tissue samples as possible. Recently, genetic analysis by microarray-based expression profiling has proven to be more informative than classical analysis of phenotype by histology and immunohistochemistry. Indeed tumours belonging to one phenotypic category could be subdivided on the basis of their gene expression profiles, and these subcategories were found to correlate to clinical outcome (Alizadeh et al., 2001; Ramaswamy et al., 2001; Singh et al., 2002) .
Critical cell biological mechanisms in gastric carcinogenesis include proliferation, apoptosis, invasion, degradation and remodelling of extracellular matrix, and stroma induction including angiogenesis. These mechanisms are to a large extent caused by genetic changes that occur at the chromosomal level. Therefore, DNA copy number profiling is a sensible approach for genotyping in gastric cancer (Kokkola et al., 1998; Sakakura et al., 1999; Guan et al., 2000; Grieken van et al., 2000; van Dekken et al., 2001; Wu et al., 2001) . Furthermore, while DNA copy number changes detected by microarray-based CGH are completely attributable to the tumour cells, gene expression profiles of tumours will be influenced by stress responses. Furthermore, expression profiles will also reflect secondary overexpressed genes that in part can be because of paracrine effects of stromal cells on the tumour cells, as well as expression patterns that are directly attributable to the admixture of nontumour stromal and inflammatory cells. In addition, in contrast to RNA, DNA can relatively easily obtained from formaldehyde fixed, paraffinembedded material, which is a major advantage in a routine clinical setting, especially outside specialized centres. Although the present study has been performed on DNA isolated from snap-frozen tissues, microarray CGH on formalin-fixed archival material has proven to be successful (data not shown).
Tumour phenotype is, at least in part, a result of the (epi)genetic changes occurring during tumour progression. However, the bulk of gastric cancers show only a limited spectrum of morphologic patterns that are classified as grade of differentiation and histological type (diffuse versus intestinal type) according to the Laure´n classification. This grouping of tumours on the basis of phenotypic resemblance in fact is rather similar to cluster analysis on the basis of correspondence in genotype between tumours. Hierarchical cluster analysis of the microarray CGH data of gastric cancers indeed resulted in two clearly distinct groups (clusters 1 and 3) and an intermediate group (cluster 2). An even further refinement could perhaps be achieved by analysing a larger series of gastric cancer. Based on the 'genotype drives phenotype' paradigm, one could have expected that the genotypic clusters would segregate with grades of differentiation or Laure´n classification. However, this was not the case, which is in line with previous observations by chromosome CGH (Grieken van et al., 2000) . More importantly, genotype does correlate with two major clinical parameters, that is, lymph node status and survival. The fact that cluster 3 tumours have more favourable prognosis than tumours from clusters 1 and 2 may prove relevant for further choice of therapy after resection. However, more and more, diagnostic pathology must provide comprehensive diagnostic information early in the decision-making process (i.e. even before operation), and preferably by using samples of limited size. In this respect, the strong correlation between genotypic clusters and lymph node status is highly relevant. Worldwide, controversy remains whether surgery for gastric cancer should include extended Figure 1 Cluster analysis of 35 gastric cancers. Hierarchical cluster analysis revealed three clusters of gastric cancers with cluster 1 containing 12 cancers, cluster 2 eight cancers, and cluster 3 fifteen cancers. Especially, clusters 1 and 3 showed clearly different patterns of chromosomal aberrations, while cluster 2 showed an intermediate pattern of chromosomal changes. The mean number of events, gains, losses, and amplifications for the different clusters are summarized in Table 1 lymph node resection or not (Sasako et al., 1995; Bonenkamp et al., 1999; Cuschieri et al., 1999) . Extended lymph node resection is associated with increased morbidity and mortality, while probably only lymph-node-positive patients would benefit from this procedure. A problem is that lymph node status frequently only becomes clear after the operation. However, preoperative endoscopy biopsies in many cases could yield enough DNA to determine genotype by microarray CGH before the time of resection, and this information could be relevant for determining the type of surgery.
The biological basis of the genotypic heterogeneity in gastric cancer is complex, and detailed analysis of this matter should include the relation between DNA copy number changes and gene expression, which is beyond the scope of the present paper. Conceptually, the existence of multiple clusters of chromosomal alterations could relate to complementary mechanisms for disrupting the same essential biological pathways regulating, for example, proliferation and invasion. In this respect, it is an intriguing question how these DNA copy number changes relate to individual genes. When the differences between clusters would have been caused by a small number of clones with major differences in copy numbers, this question could have been answered relatively easily. However, this appears not to be the case, the vast majority of discriminating copy number changes (Figure 3 ) represent gains or losses of larger chromosomal regions, while the amplitude of the discriminating copy number changes remains limited. Analysis of substantially larger series of cases will enable to narrow down the common regions of overlap for these discriminating chromosomal loci, which can then be explored with contig arrays. These contig arrays may reveal amplifications within such a common region of interest that otherwise could have been missed, and this can be a strong indication of the actual genes involved (Varis et al., 2002; Weiss et al., 2003) . By means of fluorescent in situ hybridization analysis and expression analysis, these candidate genes can be validated (Varis et al., 2002) . Then again, in many instances, the function of these genes in relation to metastatic potential and prognosis may not be immediately clear. For these reasons, at the present moment, the relation between cluster membership and individual genes cannot yet be resolved.
As mentioned above, the amplitudes of the copy number changes (i.e. the log 2 ratios) that were observed in the present study are relatively small in comparison with, for example, breast cancers. With chromosome CGH, similar 'amplitude differences' have been observed in gastric and colorectal cancers versus breast cancer (Hermsen et al., 1998; 2002; Grieken van et al., 2000) . Amplitudes of gains and losses were lower in colorectal and gastric than in the breast cancers, but nevertheless they were reproducible and consistent with literature. This could be explained by higher tumour heterogeneity in gastric and colorectal cancer than in breast cancer. Fluorescence in situ hybridization experiments on gastric cancers on chromosome 20q support this idea (Weiss et al., 2003) . Given their clinical relevance, a biological significance of these low-level changes must exist, but their effect in terms of gene expression remains to be determined.
In conclusion, genomic profiling of gastric adenocarcinomas based on microarray analysis of chromosomal copy number changes predicts prognosis and allows for discriminating a subgroup of patients with high risk of lymph node metastasis. This latter observation could clinically become relevant for selecting candidates for extended lymph node resection.
Materials and methods

Material
In total, 35 patients with primary gastric adenocarcinoma who had undergone gastrectomy, and of which fresh-frozen Figure 2 To sort the BAC clones by their contribution to discriminating the different clusters, ANOVA with 'leave-oneout' cross validation was performed. This yielded a set of 204 clones as most relevant for discerning the three clusters. The 1739 clones are sorted on the X-axis by their P-value in the ANOVA (right Y-axis) and by the amount of times the clone had a P-value o0.0001 (ranging from 0 to 35 (left Y-axis). All the 204 selected clones had >10 times a P-value o0.0001 in the 'leave-one-out' analysis. The vertical line demarcates the 204th clone material was available, were included in the study. Of these, 26 patients were male, and nine were female, with a mean age of 67.4 years (range 32-90). In all, 25 carcinomas were of the intestinal type according to the Laure´n classification (Lauren, 1965) , five were of the diffuse type, and five showed a mixed histology. Tumours with cohesive tumour cell proliferations were classified as intestinal. In all these cases (remnants of) glandular differentiation was present, and in most cases intestinal metaplasia could be observed in the adjacent mucosa. Tumours with a diffusely infiltrating proliferation of individual tumour cells, frequently with signet cell features, were classified as diffuse-type carcinomas. Occasionally in these tumours, a relation with the glandular layer of the gastric mucosa was observed. Tumours that showed both cohesive parts and diffusely infiltrating solitary tumour cells were classified as mixed types. In total, 11 tumours were moderately differentiated and 24 poorly differentiated. Two tumours were stage I, two were stage II, 23 were stage III, and eight were stage IV. In all, 12 patients were lymph node negative and 23 lymph node positive. Follow-up data were available in 33 of 35 (94%) of cases. DNA was isolated from snap-frozen tumour samples taken from the gastrectomy specimens. The samples were obtained from the archives of the department of Pathology of the VU University Medical Centre. Only cases that had a tumour content of >75% in the (sandwich) haematoxylin and eosin (H&E)-stained sections, taken before and after the sections used for DNA isolation, were included, normal human male genome DNA was isolated from lymphocytes obtained from a blood bank. DNA isolation was performed following the manufacturer's instructions (Qiamp Tissue Kit -QIAgen Inc., Valencia, CA, USA), with some modifications as described before (Weiss et al., 1999) .
Microarrays
Microarrays were produced as described previously (Snijders et al., 2001) . In short, DNA isolated from BAC clones was amplified using ligation-mediated PCR to generate representations of these human BAC DNAs. The DNAs were spotted on chromium-coated microscope slides using a custom built arrayer. Genomewide scanning arrays were used as described before (Pinkel et al., 1998; Albertson et al., 2000; Snijders et al., 2001) . The scanning array comprised DNA from 2275 BAC and P1 clones spotted in triplicate, evenly spread across the whole genome. Since the size of the complete human genome is approximately 3289 Mb (Sudbery, 2002) , and the mean length of a BAC clone is around 100-200 kb, the array used here had an average resolution of 1.4 Mb. Complete coverage of the human genome would require a microarray of approximately 30 000 clones. Each clone contains at least one STS for linkage to the sequence of the human genome (http://qenome.ucsc.edu), which provides the opportunity to identify which genes are located at the chromosomal region to which the BAC maps. Since the average gene density is 9-14 genes per Mb (Sudbery, 2002) , spots on this microarray can contain more than a single gene.
Chromosome X-clones (n ¼ 61) were discarded from further analysis, since all tumour samples were hybridised to male reference DNA, leaving 2214 clones per array to be evaluated.
Comparative hybridisation
Test and reference genomic DNA (300-500 ng of each) were labelled by random priming (BioPrime DNA labelling system, Gibco BRL) in a 50 ml reaction with Cy3 dCTP (Amersham Pharmacia Biotech) and Cy5 dCTP (Amersham Pharmacia Biotech), respectively, as described previously (Snijders et al., 2001) . Nonincorporated nucleotides were removed using a Sephadex G-50 spin column. Labelled DNA (B600-1000 ng of input DNA) was mixed with Cot-1 DNA (80-100 mg; Gibco Figure 3 'Copy number signatures' of the three clusters. The average log 2 ratios of the clones that contributed most to the difference between the three clusters are plotted along the X-axis for all three clusters, sorted from 1pter to Xqter. Chromosome 20, for example, shows gain in cluster 1, no aberration in cluster 2, and is partly lost in cluster 3 BRL) and ethanol precipitated. The precipitated DNA was dissolved in hybridisation mix (50 ml) to achieve a final composition of 50% formamide, 10% dextran sulphate, 2 Â SSC, 4% SDS, and 500 mg yeast tRNA. The hybridisation solution was heated to 701C for 10-15 min to denature the DNA, and incubation was subsequently continued at 371C for approximately 60 min to allow blocking of the repetitive sequences. A ring of rubber cement was applied closely around the array to form a well, into which we added 50 ml of slide blocking solution containing 250 mg salmon sperm DNA in a final composition of 50% formamide, 10% dextran sulphate, 2 Â SSC, and 4% SDS. After a 30 min incubation at room temperature, approximately three-quarters of the blocking solution was removed, and the denatured and reannealed hybridization mixture was added. The arrays were placed on a slowly rocking table (1 r.p.m.) at 371C to allow hybridization to occur over 48-72 h. After hybridisation, slides were washed once in 50% formamide, 2 Â SSC, pH 7, at 451C for 15 min, and once in PN buffer (PN: 0.1 m sodium phosphate, 0.1% nonidet P40, pH 8) at room temperature for 15 min. Excess liquid was drained from the slides and the array was mounted in 90% glycerol, 10% PBS, 1 mm DAPI solution to counterstain the DNA targets.
Image acquisition
Image acquisition and analysis, and data extraction were performed as described previously (Pinkel et al., 1998) . In short, DAPI, Cy3, and Cy5 images were captured using a CCD-based imaging system.
Data analysis and statistics
UCSF SPOT software (Jain et al., 2002) (http://jainlab.ucsf.edu/Projects.html), was used to automatically segment the spots based on the DAPI images, perform local background correction and to calculate various measurement parameters, including log 2 ratios of the total integrated Cy3 and Cy5 intensities for each spot. A second custom program, SPROC (http://jainlab.ucsf.edu/Projects.html), was used to associate clone identities and a mapping information file with each spot, so that the data could be plotted relative to the position of the BACs on the September, 2000 freeze of the draft human genome sequence (http://genome.ucsc.edu). The SPROC output consists of log 2 transformed averaged fluorescence ratios of the triplicate spots for each clone, standard deviations of the triplicates, and plotting position for each clone on the array. Ratios of clones for which only one of the triplicates remained after SPROC analysis were excluded from further analysis.
Chromosomal aberrations were classified as a gain when the normalized log 2 transformed fluorescence ratio was higher than 0.2; as a loss when this ratio was below À0.2. Neighbouring clones with a similar log 2 transformed fluorescence ratio exceeding these borders were regarded to belong to the same chromosomal gain or loss, respectively. Steep copy number changes with the graph showing a peak rather than a plateau, with a minimal normalized log 2 transformed fluorescence ratio of 1.0 or larger, were classified as amplifications. Multiple gains, losses, and amplifications were counted as separate events.
Descriptive statistics of microarray CGH variables are provided. Correlations between continuous variables were analysed by Pearson's w 2 test. Univariate analyses of microarray CGH data in relation to clinicopathological variables were performed using Student's t-test or the one-way analysis of variance (ANOVA) test.
Genomic profiling
To analyse the distribution of genomic profiles in this gastric cancer series, hierarchical cluster analysis was carried out with Cluster and Treeview software (http://rana.lbl.gov/EisenSoftware.htm) (Eisen et al., 1998) . Two-dimensional, complete linkage hierarchical cluster analysis (of both tumours and log 2 ratios) was performed without 'self-organizing map' preclustering, using un-centred correlation as similarity metric. Clones with more than 7 (>20%) missing values were discarded, leaving 1739 clones in the analysis. To validate the outcome of the cluster analysis, it was repeated 35 times using a 'leave-oneout' approach.
To achieve data reduction after hierarchical cluster analysis and to obtain genomic relative copy number signatures of each cluster, the significance of the differences in mean normalized log 2 transformed fluorescence ratios between clusters was tested for every clone by means of one-way ANOVA with 'leave-one-out' cross validation (Veer 't et al., 2002) . Genomic relative copy number signatures were based on those clones for which the one-way ANOVA P-values were o0.0001. For analysing cluster membership in relation to clinicopathological variables, significance of differences between clusters for continuous variables was analysed by means of ANOVA, while discrete variables were analysed by cross tabs and Pearson w 2 testing. Univariate survival analysis was carried out with the logrank test. All statistical analyses were carried out with SPSS software version 10, and P-values o0.05 were regarded significant, unless otherwise specified. ANOVA with 'leaveone-out' cross validation was performed with R software version 1.5.0 (www.r-project.org).
Abbreviations CGH, comparative genomic hybridisation; H&E, haematoxylin & eosin.
